ResMed Inc (NYSE:RMD) is expanding the availability of its AirSense 11 platform worldwide, which is expected to drive ongoing momentum. The masks and accessories segment saw an 11% year-over-year ...

as we get full AirSense 11 capabilities, everyone who's at that five-year point gets the chance to say, ‘Yes, I want the latest and greatest therapy.’” ‘It will be a benign pricing environment’ ...

ResMed stands to benefit from Philips’ significant product recall and the launch of its new flagship product, AirSense 11. Market share gains from Philips’ product recall may be limited as ...

After hours: November 15 at 7:35 PM EST Loading Chart for RMD ...

Oct 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the ...

Learn More ResMed Inc (ASX: RMD) shares have extended gains this month, closing at fresh 52-week highs of $39.07 apiece on Monday. They have since retreated to $37.72 at the time of writing after ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at https://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD ...

For the three months ended 30 September, ResMed reported an 11% increase in revenue to US$1,224.5 million. This was largely in line with consensus estimates for the period. Management advised that ...